Latest Research and Articles
-
How Libor rate rigging has put hospitals in crisis
Marketisation and PFI / PPPs, Health service reform
-
Reviewer’s commentary on ‘Should oral misoprostol be used to prevent postpartum haemorrhage in home-birth settings’ in low-resource countries? A systematic review of the evidence’ [Huntley et al 2012]
Pharmaceuticals and clinical trials, Epidemiology & research methods
-
India’s patent laws under pressure
Pharmaceuticals and clinical trials
-
NHS franchising: the toxic world of globalised healthcare is upon us
Marketisation and PFI / PPPs
-
Rethinking WHO guidance: review of evidence for misoprostol use in the prevention of postpartum haemorrhage
Pharmaceuticals and clinical trials, Epidemiology & research methods
Professor Allyson Pollock
Prof Allyson Pollock is professor of public health research and policy at Queen Mary, University of London. She set up and directed the Centre for International Public Health Policy at the University of Edinburgh from 2005 to 2011, and prior to that she was Head of the Public Health Policy Unit at UCL and Director of Research & Development at UCL Hospitals NHS Trust.
She trained in medicine in Scotland and became a consultant in public health medicine in 1991. Her research interests include globalisation; privatisation, marketisation and PFI / PPPs; health services; regulation and trade; pharmaceuticals and clinical trials; and childhood injuries.
She is the author of NHS plc and co-author of The New NHS: A Guide
